Skip to main content
Top
Published in: European Journal of Pediatrics 10/2011

01-10-2011 | Short Report

Management of ligneous conjunctivitis in a child with plasminogen deficiency

Authors: Helen Pergantou, Dimitra Likaki, Maria Fotopoulou, Olga Katsarou, Panagiota Xafaki, Helen Platokouki

Published in: European Journal of Pediatrics | Issue 10/2011

Login to get access

Abstract

Plasminogen deficiency, a rare autosomal recessive disorder, is classified as type I (hypoplasminogenemia) or type II (dysplasminogenemia). Hypoplasminogenemia is characterized by impaired wound healing while ligneous conjunctivitis (LC) is its main manifestation presenting with redness of the conjunctivae and progression to pseudomembranes' formation on the palpebral surfaces. A 4-year-old girl with LC in her left eye and impaired vision was referred to our unit. The conjunctival membranes had been already excised twice, followed by recurrences. Soon after the third recurrence, a probable diagnosis of LC was suggested, confirmed by a reduced plasminogen activity at 20% (normal values 80–120%). Both of her parents have slightly reduced plasminogen levels (50–60%) without any relevant symptom. Fresh frozen plasma (FFP) was administered systemically and topically, initiating 2 days before surgical removal of pseudomembranes with electrocautery under general anaesthesia. Systemic FFP was administered for 12 days postoperatively, along with topical use; the later was continued thereafter for 3 months. No recurrence was noticed. The vision was improved. Two weeks after cessation of the topical treatment, pseudomembranes reappeared. Topical application of FFP was reinitiated soon thereafter, and the girl underwent a second operation to have the conjunctival pseudomembranes removed. The perioperative therapeutic management was as previously described. Systemic treatment was stopped at the end of the tenth day while topical application of FFP was being continued until now, 10 months postoperatively. No recurrence has been observed and the vision remains at 9/10. Conclusion: Since surgical excision of the conjunctival pseudomembranes alone in patients with LC does not protect from recurrences, the perioperative administration of FFP, both systemically and topically improves the outcome. Furthermore, the long-term application of topical FFP preparations seems to prevent recurrences and has a protective effect on the vision of these patients.
Literature
1.
go back to reference Borel MG (1933) Un nouveau syndrome palpebral. Bull Soc Fr Ophthalmol 46:168–180 Borel MG (1933) Un nouveau syndrome palpebral. Bull Soc Fr Ophthalmol 46:168–180
2.
go back to reference Bouisson M (1847) Ophthalmie sur-aigue avec formation de pseudomembranes a la surface de la conjoctive. Ann Ocul 17:100–104 Bouisson M (1847) Ophthalmie sur-aigue avec formation de pseudomembranes a la surface de la conjoctive. Ann Ocul 17:100–104
3.
go back to reference Caputo R, Pucci N, Mori F, Secci J, Novembre E, Frosini R (2008) Long-term efficacy of surgical removal of pseudomembranes in a child with ligneous conjunctivitis treated with plasminogen eyedrops. Thromb Haemost 100:1196–1198PubMed Caputo R, Pucci N, Mori F, Secci J, Novembre E, Frosini R (2008) Long-term efficacy of surgical removal of pseudomembranes in a child with ligneous conjunctivitis treated with plasminogen eyedrops. Thromb Haemost 100:1196–1198PubMed
4.
go back to reference Gürlü VP, Demir M, Alimgil ML, Erda S (2008) Systemic and topical fresh-frozen plasma treatment in a newborn with ligneous conjunctivitis. Cornea 27(4):501–503PubMedCrossRef Gürlü VP, Demir M, Alimgil ML, Erda S (2008) Systemic and topical fresh-frozen plasma treatment in a newborn with ligneous conjunctivitis. Cornea 27(4):501–503PubMedCrossRef
5.
go back to reference Lijό Pavia J (1924) Tumor inflammatorio fungoso recidivante de la conjunctiva palpebral. Semana Med 31:326–331 Lijό Pavia J (1924) Tumor inflammatorio fungoso recidivante de la conjunctiva palpebral. Semana Med 31:326–331
7.
go back to reference Mirshahi S, Soria J, Nelles I et al (1996) Plasminogen activators in human corneal fibroblasts: secretion, cellular localization and regulation. Fibrinolysis Proteolysis 10:255–262 Mirshahi S, Soria J, Nelles I et al (1996) Plasminogen activators in human corneal fibroblasts: secretion, cellular localization and regulation. Fibrinolysis Proteolysis 10:255–262
8.
go back to reference Schott D, Dempfle C-E, Beck P, Liermann A, Mohr-Pennert A, Goldner M et al (1998) Therapy with purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med 339(23):1679–1686PubMedCrossRef Schott D, Dempfle C-E, Beck P, Liermann A, Mohr-Pennert A, Goldner M et al (1998) Therapy with purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med 339(23):1679–1686PubMedCrossRef
9.
11.
go back to reference Tabbara KF (2004) Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma. Am J Ophthalmol 138(2):299–300PubMedCrossRef Tabbara KF (2004) Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma. Am J Ophthalmol 138(2):299–300PubMedCrossRef
Metadata
Title
Management of ligneous conjunctivitis in a child with plasminogen deficiency
Authors
Helen Pergantou
Dimitra Likaki
Maria Fotopoulou
Olga Katsarou
Panagiota Xafaki
Helen Platokouki
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 10/2011
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-011-1483-9

Other articles of this Issue 10/2011

European Journal of Pediatrics 10/2011 Go to the issue